Benefit-Risk Communication Toolkit Builder for Patient-Facing Regulatory Documents
Regulatory medical writers and patient engagement specialists use this agent when developing patient-facing benefit-risk communication materials — such as FDA-required Medication Guides, EMA package leaflets, or Risk Evaluation and Mitigation Strategy (REMS) communication materials — that must be comprehensible to patients with limited health literacy while remaining accurately aligned to approved label language.